Receive our newsletter – data, insights and analysis delivered to you
  1. News
July 14, 2020

Paige raises funds for AI-native digital pathology ecosystem

US-based computational pathology company Paige has secured an additional investment of $15m from Goldman Sachs Merchant Banking Division as part of its previously announced Series B financing round.

US-based computational pathology company Paige has secured an additional investment of $15m from Goldman Sachs Merchant Banking Division as part of its previously announced Series B financing round.

Goldman Sachs has now invested a total of $20m in the round, which also saw an additional $5m investment from Healthcare Venture Partners, which has previously invested $10m.

The additional investments have brought the total funding raised in Series B round to $70m. Overall, the company has raised over $95m.

Paige intends to use the new capital to accelerate the global position in transforming pathology workflows in the field of cancer. The proceeds will also support the company’s efforts to create custom diagnostic and clinical trial solutions in association with biopharma companies.

Paige CEO Leo Grady said: “We appreciate the continued recognition and support we have received from Goldman Sachs as we gain traction and prove early results in the clinical and biopharma space.

“This new funding will help ensure that the Paige Platform and our advanced computational pathology products will drive the next generation of pathology and improve cancer care globally.”

Content from our partners
“Everything is custom”: Behind the scenes of medical wire solutions
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials

Following the financing, Goldman Sachs managing director David Castelblanco has joined the board of directors of Paige.

Commenting on the development, Castelblanco said: “We have been very impressed with the company and its pace of development. We are excited to increase our commitment to support Leo, Thomas and the Paige team’s transformative work with artificial intelligence and machine learning in the cancer field.”

Founded in 2017, Paige develops computational pathology products that enable patients and their care teams to make more informed treatment decisions.

Last year, the company partnered with Royal Philips to integrate its clinical-grade artificial intelligence technologies into routine pathological practice.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU